Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Res ; 61(8): 3308-13, 2001 Apr 15.
Article in English | MEDLINE | ID: mdl-11309285

ABSTRACT

Human tumor cell progression and metastasis are partially dependent on the ability of a tumor cell to adhere to the proteins of the extracellular matrix (ECM) and survive at the distant location. Six novel D-amino acid-containing peptides were analyzed for their ability to adhere to human prostate tumor cells, support tumor cell adhesion, and inhibit tumor cell adhesion to ECM proteins or human dermal fibroblasts. Of these, two peptides called RZ-3 (kmviywkag) and HYD-1 (kikmviswkg) bound to tumor cell surfaces and compared favorably with the previously reported AG-73 (RKRLQVQLSIRT) L-amino acid peptide, as determined by fluorescence-activated cell sorting analysis. A scrambled peptide derivative of HYD-1, called HYDS-1 (wiksmkivkg), was not active. The RZ-3, HYD-1, and AG-73 peptides supported maximal cancer cell adhesion at 5 microg, 10 microg, and 50 microg/well, respectively. The ECM proteins fibronectin, laminin 1, and collagen IV supported maximal cell adhesion at 1 microg, >10 microg, and 50 microg/well, respectively. Prostate tumor cell adhesion to immobilized RZ-3 and HYD-1 peptides was inhibited by alpha2-6- and beta1-integrin-blocking antibodies. Conversely, tumor cell adhesion to a beta1-integrin-specific antibody was blocked by both RZ-3 and HYD-1. Epithelial cell adhesion to dermal fibroblasts was inhibited by HYD-1 and unaffected by the scrambled peptide, HYDS-1. Cell adhesion to immobilized peptides was unaffected by EDTA. The soluble RZ-3 and HYD-1 peptides inhibited tumor cell adhesion to each of the immobilized four ECM proteins (1.0 microg/well) in a time- and concentration-dependent manner. The IC(50) of the RZ-3 peptide for blocking adhesion to fibronectin, laminin 1, laminin 5, and collagen IV was 2.4 microg, 1.8 microg, 4.6 microg, and 2.8 microg/well, respectively. The IC(50) of the HYD-1 peptide for blocking adhesion to fibronectin, laminin 1, laminin 5, and collagen IV was 6.9 microg, 5.7 microg, >10 microg, and 6.2 microg/well, respectively. Taken together, these results indicate that RZ-3 and HYD-1 are biologically active D-amino acid-containing peptides that can themselves support tumor cell adhesion and can inhibit tumor cell adhesion to immobilized ECM proteins or dermal fibroblasts.


Subject(s)
Carcinoma, Squamous Cell/pathology , Extracellular Matrix Proteins/metabolism , Mouth Neoplasms/pathology , Oligopeptides/pharmacology , Prostatic Neoplasms/pathology , Carcinoma, Squamous Cell/metabolism , Cell Adhesion/drug effects , Coculture Techniques , Collagen/metabolism , Fibroblasts/cytology , Fibroblasts/metabolism , Fibronectins/metabolism , Humans , Integrins/metabolism , Laminin/metabolism , Laminin/pharmacology , Male , Mouth Neoplasms/metabolism , Peptide Fragments/pharmacology , Prostatic Neoplasms/metabolism , Skin/cytology , Tumor Cells, Cultured
2.
J Exp Child Psychol ; 73(4): 266-88, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10419644

ABSTRACT

Children's memory for a specific episode of a repeated event was investigated in 2 experiments. In Experiment 1, eighty 4- and 7-year-olds experienced a standard novel event 1, 2, or 4 times, followed by an episodic event for those children who had multiple standard event experiences. The episodic event involved the addition of both schema-typical and schema-atypical activities to the standard event. Following a 1-week delay, children were asked to recall both event types. Four-year-olds were more confused than older children regarding when the new activities had been experienced, although experience improved memory for the schema-atypical activities. In contrast, 7-year-olds were able to establish more accurate memories for both the schema-typical and the schema-atypical changes. Experiment 2 demonstrated that 4-year-olds could, however, establish distinct memories for both types of changes when the standard event was simplified. The results are discussed in terms of the development of the relation between script memory and memory for a specific instance of an event.


Subject(s)
Memory/physiology , Child , Child Development/physiology , Child, Preschool , Female , Humans , Male
3.
Oncogene ; 16(4): 453-8, 1998 Jan 29.
Article in English | MEDLINE | ID: mdl-9484834

ABSTRACT

The p53 tumor suppressor protein binds two copies of a ten base pair motif that is degenerate in eight out of ten bases and conforms to the sequence, 5'PuPuPuC(A/T)(T/A)GPyPyPy-3'. As a consequence of this high degree of degeneracy, p53 response elements show a great deal of variation and it has been speculated that the variation aids in the selective activation of p53 responsive genes by specific stimuli. Here, we examined the DNA binding characteristics of several different p53 protein complexes present in nuclear extracts prepared from a cell line expressing the murine temperature sensitive p53 protein, p53val135. Interestingly, the complexes exhibited a distinct preference for binding to some p53 response elements and not others. A critical determinant of this specificity was the sequence at the center of the ten base pair motif and alteration of a single base within this region was sufficient to alter the set of complexes that associated with the oligonucleotide. In addition, thermal denaturation experiments demonstrated that some complexes could bind DNA even though the p53val135 protein had a mutant conformation. Our results are consistent with the hypothesis that p53 can distinguish between various response elements and suggest that this selectivity is manifested, in part, by the sequence of the motif and conformation of the p53 protein.


Subject(s)
DNA-Binding Proteins/metabolism , DNA/metabolism , Transcription Factors/metabolism , Tumor Suppressor Protein p53/metabolism , Cell Nucleus/metabolism , DNA-Binding Proteins/chemistry , Hot Temperature , Transcription Factors/chemistry , Tumor Suppressor Protein p53/chemistry
4.
Cell Growth Differ ; 8(9): 941-9, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9300177

ABSTRACT

The p53 tumor suppressor is a transcription factor that regulates several pathways, which function collectively to maintain the integrity of the genome. Nuclear localization is critical for wild-type function. However, the signals that regulate subcellular localization of p53 have not been identified. Here, we examine the effect of ionizing radiation on the subcellular localization of p53 in two cell lines in which p53 is normally sequestered in the cytoplasm and found that ionizing radiation caused a biphasic translocation response. p53 entered the nucleus 1-2 h postirradiation (early response), subsequently emerged from the nucleus, and then again entered the nucleus 12-24 h after the cells had been irradiated (delayed response). These changes in subcellular localization could be completely blocked by the free radical scavenger, WR1065. By comparison, two DNA-damaging agents that do not generate free radicals, mitomycin C and doxorubicin, caused translocation only after 12-24 h of exposure to the drugs, and this effect could not be inhibited by WR1065. Hence, although all three DNA-damaging agents induced relocalization of p53 to the nucleus, only the translocation caused by radiation was sensitive to free radical scavenging. We suggest that the free radicals generated by ionizing radiation can signal p53 translocation to the nucleus.


Subject(s)
Cell Nucleus/radiation effects , Gamma Rays , Signal Transduction/radiation effects , Tumor Suppressor Protein p53/metabolism , Tumor Suppressor Protein p53/radiation effects , Animals , Biological Transport/radiation effects , Cell Line , Free Radicals/radiation effects , Humans , Intracellular Fluid/metabolism , Intracellular Fluid/radiation effects , Mice , Tumor Cells, Cultured
5.
Mol Divers ; 2(1-2): 19-28, 1996 Oct.
Article in English | MEDLINE | ID: mdl-9238629

ABSTRACT

Tumor cell progression is dependent in part on the successful adhesive interactions of the cells with the extracellular matrix. In this study, a new approach is described to isolate linear peptide ligand candidates involved in cellular adhesion. A synthetic combinatorial peptide library based on the 'one-bead-one-peptide' concept was incubated with live human prostate cancer cells for 90 min at 37 degrees C. The peptide bead coated with a monolayer of cells was then isolated for microsequencing. The DU145 (DU-H) cells were chosen since they have been previously characterized as containing elevated levels of a laminin receptor for cell adhesion, the alpha 6 beta 1 integrin on the cell surface. The use of a function-blocking antibody (GoH3) allows for the detection of peptides which are alpha 6-specific ligand candidates. From two different libraries (linear 9-mer and 11-mer) of a total of 1,500,000 beads, 68 peptide beads containing attached cells were isolated. These positive beads were then retested to determine the ability of the GoH3 antibody to block binding of the cells to the peptide beads. The alpha 6 integrin candidate peptide beads (five in total) were recovered and two of the beads were microsequenced. These two peptides, RU-1 (LNIVS-VNGRHX) and RX-1 (DNRIRLQAKXX), resemble the previously reported active peptide sequences (GD-2 and AG-73) from native laminin. The RU-1, RX-1 and AG-73 peptides were tested for their ability to support cell attachment and to bind the cell surface of DU-H prostate carcinoma cells in suspension using fluorescence-activated cell-sorting (FACS) analysis. Both RU-1 and AG-73 peptides supported cellular attachment within 1 h. In contrast, after 1 h, EHS laminin supported both cellular attachment and spreading. The RX-1 peptide exhibited only weak binding to the DU-H prostate carcinoma cells. FACS analysis indicated that AG-73 peptide attached to tumor cell surfaces over a range of concentrations, whereas the RU-1 peptide showed a homogeneous concentration required for attachment. The described strategy for screening a random peptide library offers three advantages: (i) ligands for conformationally sensitive receptors of adhesion can be isolated using live cells; (ii) specific binding can be selected for using function-blocking antibodies; and (iii) peptides supporting adhesion independent of spreading properties can be distinguished. In principle, specific adhesive peptides without prior knowledge of the sequence could be isolated for any epithelial cell surface receptor for which a function-blocking reagent is available.


Subject(s)
Cell Adhesion Molecules/isolation & purification , Peptide Library , Peptides/chemistry , Antigens, CD/metabolism , Carcinoma , Cell Adhesion , Cell Adhesion Molecules/physiology , Flow Cytometry , Humans , Integrin alpha6 , Integrins/metabolism , Male , Microspheres , Peptides/chemical synthesis , Peptides/physiology , Prostatic Neoplasms , Protein Binding , Surface Properties , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...